DILTIAZEM EXTENDED-
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Defense Logistics Agency award SPE2DP21F4690 was issued to DMS Pharmaceutical Group Inc. for the procurement of Diltiazem Extended, identified by NSN 6505015054619. This action was processed as a delivery order under the broader master contract SPE2DX15D9383, which was originally established on April 30, 2015, with a total award value of 4,999,999.00 dollars. On August 25, 2026, modification P00001 was executed for delivery order SPE2DP21F4690. This modification resulted in the total cancellation and termination for convenience of the order under FAR 52.212-4(l). The action cancelled CLIN 0001 due to non-performance and a mutual agreement to cancel, effectively reducing the order amount to zero dollars.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
